Matt Stoller delivers a blistering indictment of the American health care system, arguing that the era of "Obamacare" is effectively over not because of political failure, but because the underlying economic model has collapsed under its own weight. He exposes a shocking reality: while premiums are skyrocketing to levels that force millions out of coverage, the money isn't paying for better care, but rather funding a bloated, luxury infrastructure of nonprofit hospitals and financial middlemen. This is a crucial read for anyone trying to understand why the system feels like it is falling apart despite record spending.
The Collapse of the Neoliberal Deal
Stoller begins by dismantling the comforting narrative that the Affordable Care Act is merely facing temporary headwinds. He argues that the fundamental bargain struck over the last fifty years—where social goods are distributed through powerful corporations rather than the state—has reached its breaking point. "The intellectual promise of Obamacare is over, even though Democrats wish it weren't so," Stoller writes. He posits that the system is paralyzed because both parties are trapped in a framework that prioritizes corporate power over patient outcomes. The right offers no real solution beyond privatization, while the left clings to a system that is no longer affordable.
The author points to staggering data to illustrate the crisis. Citing a KFF study, he notes that family plans now cost $27,000, a figure that has jumped 6% in a single year after two years of similar increases. Another index suggests the cost for a family of four could hit $35,000 by 2025, triple what it was two decades ago. "That's crazy, and what is going to happen is a lot of those people are simply going to forego insurance," Stoller observes. This isn't just a policy dispute; it is a systemic failure where the cost of entry is becoming prohibitive for the very people the system was designed to protect.
Critics might argue that inflation and post-pandemic utilization rates are the primary drivers of these costs, a point Stoller addresses but ultimately dismisses as insufficient. He asks a piercing question that cuts through the standard economic explanations: "Where's all this money going?!?!" If spending is up, why are rural hospitals closing, pharmacies going bankrupt, and generic drug manufacturers shutting down factories? The answer, he suggests, lies not in the cost of care, but in the cost of the system itself.
The answer, in miniature, was provided to us by the Chief Cardiologist at the University of Miami Miller School of Medicine, Yiannis Chatzizisis.
The Luxury of Nonprofit Monopolies
Stoller shifts the focus from abstract premiums to the tangible reality of where the money flows. He describes a new medical facility at the University of Miami not as a place of healing, but as a "gold-plated marble palace" complete with LED art, ornate chandeliers, and a grand piano played by a professional musician. This facility, owned by a tax-exempt nonprofit, exemplifies the absurdity of the current model. "You will not hear about the urology professor at the University of Miami paid $4 million a year, or the salary paid to the guy playing the piano in a marble medical chateau," Stoller writes. The money is being siphoned off by executive salaries and vanity projects rather than invested in capacity or affordability.
The author highlights that hospital care is the largest chunk of health care spending, dwarfing pharmaceutical costs, yet it is the sector with the least transparency. He argues that these institutions have become monopolies, protected by government concessions and tax breaks, which allows them to buy up doctor practices and dictate prices. "The lack of any consistent pricing is the key feature in U.S. health care, in everything from drug distribution and reimbursement to hospital billing to medical supply procurement," he explains. This lack of price consistency is not a bug; it is a feature of a system designed to maximize corporate power rather than public health.
From Care to Corporate Sludge
The piece traces the historical evolution of this dysfunction, identifying a pivotal shift in the 1970s when the concept of "managed care" was introduced. Stoller explains that this was a response to the fear of "moral hazard"—the idea that patients would over-consume care if it was too cheap. "Someone needed to do the rationing, but it couldn't be the state, since the right would scream bloody murder. But conservatives could allow rationing as long as it was done by a banker, or firms who came into existence like United Health Care," he notes. This created a system where financial middlemen, rather than doctors or the state, control access to care.
This consensus, embraced by both parties, led to the rise of vertically integrated giants that control everything from insurance to pharmacy benefits. The result is a nightmare of bureaucracy where insurance is no longer a safety net but a complex financial product designed to extract value. "The value of insurance is increasingly questionable. It's supposed to make things easier, but it's so complex now, some companies offer their employees an extra perk of someone to help them navigate their insurance," Stoller writes. The system has become so convoluted that it requires its own industry just to navigate it.
Every time there's a problem with health care, the ideological response is not to fix the system, but to add another layer of financial complexity.
Critics might argue that managed care has successfully controlled costs in some areas or that the complexity is necessary to manage risk. However, Stoller's evidence suggests that the primary outcome has been the transfer of wealth from patients and providers to a new class of corporate intermediaries, leaving the actual delivery of care increasingly fragile.
Bottom Line
Stoller's most powerful contribution is his refusal to accept the standard political excuses for the health care crisis, instead pointing directly to the structural rot of corporate consolidation and the luxury of the nonprofit sector. His argument is vulnerable only in that it offers a diagnosis rather than a clear political roadmap for dismantling these entrenched interests. The reader must now watch to see if the coming premium hikes will finally break the political paralysis that has allowed this system to fester for decades.